Company Info
| Year Established: | 2017 |
Contacts
| Primary: | Stefan Scherer, MD, PhD President & CEO |
| Other: | Christopher J DeRespino CBO Sean Harper, MD Chair Bryan A. Irving Ph.D. CSO Estelle Marrer-Berger, Ph.D. CDO |
Company Description
3T is an immunotherapy company developing next-generation, transformative therapies for the treatment of solid tumors and other immune-mediated diseases in broad patient populations.
